The first doses of Pfizer’s COVID-19 vaccine for children aged 5-11 years arrived in Canada on Sunday.
“Today we reached another milestone in our fight against #COVID19 – the first doses of the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 have arrived in Canada!,” Filomena Tassi, Minister of Public Services and Procurement, tweeted.
Tassi further added “By next Friday, the initial 2.9M doses will be here – enough for a first dose for every eligible child.”
The Government of Canada on Friday approved Pfizer’s COVID-19 vaccine for children aged 5 to 11 years of age.
“After a thorough and independent scientific review of the evidence, the Department has determined that the benefits of this vaccine for children between 5 and 11 years of age outweigh the risks. Health Canada has authorized a two-dose regimen of 10 micrograms to be administered three weeks apart, which is a lower dose than the 30 micrograms two-dose regimen authorized for people 12 years of age and older,” the Health Canada said in a statement.
The statement further added that the clinical trial showed that the immune response in children 5 to 11 years of age was comparable to the immune response in people 16 to 25 years of age. The vaccine was 90.7% effective at preventing COVID-19 in children 5 to 11 years of age and no serious side effects were identified.